Webinar | Roadmap to Market for Cell and Gene Therapies
October 12, 2020
View the On-Demand Webinar
Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.
Webinar | Reducing Study Build Time from Weeks to Days
October 1, 2020
View Webinar On-Demand
Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.
Cell and Gene Meeting On The Mesa
August 3, 2020
Meet Veristat at the Virtual event taking place October 12-14, 2020.
Gene Therapy for Rare Disorders Europe
August 3, 2020
Meet Veristat at the Virtual event taking place 26-28 October 2020.
Webinar | Minimize Disruption of Your Oncology Trial
June 4, 2020
View the On-Demand Webinar
As the world begins to relax restrictions, what are the lessons learned that can catapult us into the next innovation in trial operations for good?View the On-Webinar
Submitting an Investigational New Drug (IND) application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready?DIA 2020 Virtual Meeting ⎪Booth 138
February 19, 2020
Meet Veristat at the Virtual US DIA Annual Meeting 2020 taking place on 14-18 June 2020, Virtual Booth #138
ASCO Annual Meeting ⎪Booth 25110
February 19, 2020
Meet Veristat at the ASCO 2020, 30 May – 1 June 2020, Booth 25110
Chief Medical Officer Summit 2020 -Outsourcing Panel Discussion
February 19, 2020